Howard Feldman

89.8k citations
242 papers · 31.3k · 11 hit papers · h-index 58

Impact in

    • Dementia and Cognitive Impairment Research
  • Neurology top 0.05%
    • Amyotrophic Lateral Sclerosis Research
    • Parkinson's Disease Mechanisms and Treatments
    • Neurological Disease Mechanisms and Treatments

Papers in

Howard Feldman

231 papers receiving 30.6k citations

Howard Feldman's Hit Papers

evoke and evoke+: design of two large-scale, double-blind, placebo-controlled, phase 3 studies evaluating efficacy, safety, and tolerability of semaglutide in early-stage symptomatic Alzheimer’s disease 2025 · 63 citations
630+7+15Years since publication2.0k4.0k6.0k

Peers

Howard Feldman
Comparison fields: 5 of 177
  • Psychiatry and Mental health 11.4k
  • Neurology 3.8k
  • Neurology 6.6k
  • Physiology 8.9k
  • Biological Psychiatry 501
Replace Monique M.B. Breteler with:
Monique M.B. Breteler Netherlands
Giancarlo Logroscino Italy
Robert J. Ivnik United States
Bradley F. Boeve United States
Alessandro Padovani Italy
Sandra Weıntraub United States
Douglas Galasko United States
Thomas G. Beach United States
Richard Mayeux United States
Leon J. Thal United States
Howard Feldman relative to Monique M.B. Breteler Netherlands Monique M.B. Breteler's profile →
Citations per field
00.5×1.5×
Monique M.B. Breteler · 1×
Citations per year

Countries citing papers authored by Howard Feldman

Since Specialization
Citations

This map shows the geographic impact of Howard Feldman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Howard Feldman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Howard Feldman more than expected).

Fields of papers citing papers by Howard Feldman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Howard Feldman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Howard Feldman. The network helps show where Howard Feldman may publish in the future.

Co-authors

The 25 scholars most cited alongside Howard Feldman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Howard Feldman Line = papers co-authored together Howard Feldman links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 242 papers — load more, or switch the sort, to bring in the rest.

#Work
1
The diagnosis of mild cognitive impairment due to Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
Hit paper breakdown →
20117417
2
Ubiquitinated TDP-43 in Frontotemporal Lobar Degeneration and Amyotrophic Lateral Sclerosis
Hit paper breakdown →
20064904
3
Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS–ADRDA criteria
Hit paper breakdown →
20073199
4
The Diagnosis of Mild Cognitive Impairment due to Alzheimer’s Disease: Recommendations from the National Institute on Aging-Alzheimer’s Association Workgroups on Diagnostic Guidelines for Alzheimer’s Disease
Hit paper breakdown →
20132165
5
A/T/N: An unbiased descriptive classification scheme for Alzheimer disease biomarkers
Hit paper breakdown →
20161210
6
Clinical diagnosis of Alzheimer's disease: recommendations of the International Working Group
Hit paper breakdown →
2021641
7
Treatment of Alzheimer's disease; current status and new perspectives
Hit paper breakdown →
2003624
8
Amyloid-related imaging abnormalities in amyloid-modifying therapeutic trials: Recommendations from the Alzheimer’s Association Research Roundtable Workgroup
Hit paper breakdown →
2011572
9
Clinical trials and late‐stage drug development for Alzheimer's disease: an appraisal from 1984 to 2014
Hit paper breakdown →
2014518
10 2003465
11 2001459
12 2010415
13 2010327
14
Efficacy and safety of tau-aggregation inhibitor therapy in patients with mild or moderate Alzheimer's disease: a randomised, controlled, double-blind, parallel-arm, phase 3 trial
Hit paper breakdown →
2016326
15 2010300
16 2005266
17 2008265
18 2006226
19 2004183
20 2008182

About Howard Feldman

Howard Feldman is a scholar working on Psychiatry and Mental health, Physiology, Neurology, Economics and Econometrics and Neurology, having authored 242 papers that have together received 31.3k indexed citations. Recurring topics across this work include Dementia and Cognitive Impairment Research (104 papers), Alzheimer's disease research and treatments (71 papers), Amyotrophic Lateral Sclerosis Research (25 papers), Health Systems, Economic Evaluations, Quality of Life (22 papers), Cholinesterase and Neurodegenerative Diseases (16 papers), Parkinson's Disease Mechanisms and Treatments (13 papers), Neurological Disease Mechanisms and Treatments (9 papers) and Frailty in Older Adults (7 papers). The work is most often cited by research in Psychiatry and Mental health (11.4k citations), Neurology (3.8k citations), Neurology (6.6k citations), Physiology (8.9k citations) and Biological Psychiatry (501 citations). Howard Feldman has collaborated with scholars based in Canada, United States and United Kingdom. Frequent co-authors include Bruno Dubois, Steven T. DeKosky, María C. Carrillo, Ronald C. Petersen, William J. Jagust, Dennis W. Dickson, David M. Holtzman, Marilyn S. Albert, Creighton H. Phelps and Nick C. Fox. Their work appears in journals such as Alzheimer s & Dementia, Neurology, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques, Neurobiology of Aging and Alzheimer s Research & Therapy.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact